A phase 1 Nature Medicine trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer.
Disclaimer: This platform allows content from paid contributors. Not every submission is checked daily. The owner disclaims endorsement of illegal activities including gambling, betting, casinos, or CBD.